| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |